K-OTC Market, Mothers Pharmaceutical and AAI Healthcare Newly Designated Companies

Kwon Yong-won, chairman of the Korea Financial Investment Association, who caused controversy after a recording of him verbally abusing a driver and employees was released, was found dead on the 6th. The police suspect that Chairman Kwon took his own life. The photo shows the Korea Financial Investment Association in Yeongdeungpo-gu, Seoul on the same day. Photo by Moon Ho-nam munonam@

[Asia Economy Reporter Hwang Yoon-joo] The Korea Financial Investment Association announced on the 23rd that it has newly designated two companies, Mothers Pharmaceutical Co., Ltd. and AAI Healthcare Co., Ltd., to the K-OTC market, with trading starting from the 27th.

The Financial Investment Association designates companies that disclose business reports and meet certain financial requirements as K-OTC tradable companies. With this designation, the total number of companies available for trading in the K-OTC market has increased to 144.

Mothers Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in natural medicine and adult disease treatments, with key products including arthritis treatments and diabetes treatments. AAI Healthcare Co., Ltd. is a healthcare company providing data-based personalized customized service solutions.

Nam Dal-hyun, Head of Market Management at the Korea Financial Investment Association, said, "Although trading has somewhat contracted due to the recent IPO market downturn, inquiries about entering the K-OTC market continue," adding, "We will continue to strive to attract promising unlisted companies to provide investors with more diverse investment opportunities."

The newly designated companies will be tradable through securities firms' HTS from the 27th. On the first trading day, trading is possible within the range of 30% to 500% of the net asset value per share, and thereafter, the price limit range will be ±30% of the previous day's weighted average price.